|Placed on:||17th November 2016|
|Expires:||16th January 2017|
Reporting to: Head of Technology Development
Inivata, a global clinical cancer genomics company, is transforming personalised healthcare in oncology by utilising the precision of circulating tumour (ctDNA) analysis. Using a simple blood sample, ctDNA testing is a new tool for oncologists to detect cancer, stratify patients, and assess individual response to treatment. Inivata’s proprietary technology is based on pioneering research from the Rosenfeld Lab at the Cancer Research UK Cambridge Institute (CRUK-CI), University of Cambridge. Inivata’s platform brings together Next-Generation sequencing (NGS) technology with proprietary algorithms and databases that guide genomic profiles to clinical outcomes. Inivata’s InVision® ctDNA assay provides a highly sensitive analysis of a strategically selected gene panel to identify actionable mutations for oncologists to treat their patients optimally. Inivata recently completed a highly successful Series A fundraising of £45m to accelerate clinical studies and commercialise the company’s first products.
Inivata is a fast-paced, dynamic startup company with founders who are pioneers in the field of ctDNA analysis. We are a dedicated team with strong foundations and leadership and are all passionate about modernising cancer care and treatment for patients. Inivata employees have both drive and determination to work successfully as individuals and as a team to revolutionise cancer care. As part of this role there will be international travel and collaboration between the US/UK offices that brings a global-community feel to Inivata as we tackle the universal disturbance of cancer together with our most advanced technology.
We are now looking to recruit a highly motivated, creative and logical individual to develop the next wave of innovative methods to transform cancer patient care. The successful applicant will work at the forefront of genomic technologies in developing novel methods for noninvasive analysis of cancer genomes, analysing ctDNA from plasma of cancer patients and other samples. Assays will be developed for use in clinical diagnostics laboratories both in the US and UK. The role is a full time, hands-on laboratory-based position.
Inivata Limited is based in Cambridge, UK.
Please send your CV, including a covering letter to: firstname.lastname@example.org quoting: 070 Technology Development Scientist in the subject line.
No agencies please. www.inivata.com